Please note: This activity is no longer available for continuing education credit.
Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.
Please note: This activity is no longer available for continuing education credit.
A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular history and dupilumab's conjunctivitis risk. Find out what the experts have to say about this doctor's dilemma.
Please note: This activity is no longer available for continuing education credit.
Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel discusses how they would approach the baby's treatment, emerging options for this vulnerable patient population, and if anything can be done now to prevent progression of the atopic march later.
Please note: This activity is no longer available for continuing education credit.
“I begged my doctor for something else – there had to be something else,” Pam.
For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of the several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.
Here to give us insight into the strategies he uses to personalize therapeutic approaches for his patients with severe psoriasis is Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine.
Tune in as Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine, shares a challenging case of a patient with both psoriasis and Crohn's disease.
A multidisciplinary approach between dermatologists and rheumatologists is required for treating and caring for patients with psoriatic arthritis (PsA). So how should these two specialists work together to achieve the best outcome for their patients? What challenges do they each face, and how can they overcome them?
Dr. Michael Greenberg, dermatologist from the Illinois Dermatology Institute, and Dr. Madelaine Feldman, Clinical Associate Professor of Medicine at Tulane University School of Medicine and practicing rheumatologist, come together to provide their perspectives from their careers on this topic.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Along with the management of psoriatic arthritis, many patients also struggle with multiple, underlying comorbidities, increasing the complexity of the disease. In a review of the associated comorbidities that can emerge from PsA, Dr. Alexis Ogdie brings another aspect to the forefront: the all-too-often underrecognized comorbidities and risk factors.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
A healthy thirty-year-old and father of two was six to eight weeks into his disease activity when he finally found his way to Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania. Revisiting this case, Dr. Odgie takes us through her PsA patient’s journey to regain his health and happiness.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
New outcome measures provide the opportunity for a more patient-inclusive assessment of psoriatic arthritis. With the help of Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania, you can implement these in clinical practice and facilitate collaborative decision-making and improved outcomes with your patients.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.
Due to the complexity of psoriatic arthritis, working with a team of physicians helps ensure all facets of this disease are being addressed, but how can you sustain a partnership? Dr. Alexis Ogdie, Assistant Professor at the University of Pennsylvania, expresses the value of multidisciplinary teams in her practice to promote a patient-centered approach.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
For the two percent of Americans diagnosed with psoriasis, proper and individualized treatment is essential in improving a patient’s quality of life, as Dr. Jennifer Caudle explains.
Many psoriatic arthritis patients struggle in determining the proper physician they should seek for treatment and care management. Since dermatologists are usually consulted first due to skin manifestations, it’s crucial that they are able to recognize the symptoms of PsA and know when to refer the patient to another specialist. Dr. Adrienne Rencic, a dermatologist in Glen Mills, PA, emphasizes the power of communication to achieve good coordination of care.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
The emotional burden of psoriatic arthritis stems from the development of skin lesions, which can be extremely damaging to a patient’s personal and professional relationships as Dr. Robin Dore explains.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
As a physician, perhaps the only thing more satisfying than successfully treating a patient’s psoriatic arthritis is hearing their sincere gratitude for the positive impact the prescribed therapy has had on their life, as Dr. Robin Dore experienced in this patient case featuring a young mother who was apprehensive to begin treatment.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Like any other condition, early detection is critical in psoriatic arthritis, but as Dr. Robin Dore proved in this unique patient case of a woman who dealt with PsA for 40 years, it’s never too late to start therapy and improve a patient’s quality of life.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Diagnosing psoriatic arthritis (PsA) requires a thorough and thoughtful exam, but how can you be sure you’re not missing any symptoms? Join Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, as he dives into the best ways to screen your PsA patients.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io